EV/EBITDA
-0.12
+0.02+14.29%
Fri, 07 Feb 2025 22:40:02 GMT
Summary
- As of February 8, 2025, APVO EV/EBITDA is -0.12, with a rise of +0.02 (+14.29%) during the most recent trading day.
- Over the past year, APVO EV/EBITDA has dropped by -0.41 (-141.38%).
- APVO EV/EBITDA is now -117.91% below its all-time high of 0.67.
Performance
APVO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APVO EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +14.3% | -15.3% | -8.1% |
1 m1 month | +33.3% | -35.3% | -21.2% |
3 m3 months | 0.0% | +1.5% | -65.5% |
6 m6 months | -300.0% | +223.3% | -74.3% |
ytdytd | +7.7% | -9.8% | -5.0% |
1 y1 year | -141.4% | +135.1% | -98.4% |
5 y5 years | +86.2% | -91.5% | -100.0% |
APVO EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -0.18 | +33.3% | |
3 m | 3-month | 0.03 | -500.0% | -0.19 | +36.8% |
6 m | 6-month | 0.04 | -400.0% | -0.19 | +36.8% |
1 y | 1-year | 0.33 | -136.4% | -0.19 | +36.8% |
3 y | 3-year | 0.67 | -117.9% | -0.34 | +64.7% |
5 y | 5-year | 0.67 | -117.9% | -7.39 | +98.4% |
alltime | all time | 0.67 | -117.9% | -68 K | +100.0% |
Aptevo Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -0.12(-7.7%) |
2024 | -0.13(-146.4%) |
2023 | 0.28(-500.0%) |
2022 | -0.07(-86.0%) |
2021 | -0.50(-91.2%) |
Date | Value |
---|---|
2020 | -5.69(+441.9%) |
2019 | -1.05(+191.7%) |
2018 | -0.36(-81.5%) |
2017 | -1.95(+95.0%) |
2016 | -1.00 |
FAQ
- What is Aptevo Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Aptevo Therapeutics?
- What is APVO EV/EBITDA year-to-date change?
- What is Aptevo Therapeutics EV/EBITDA year-on-year change?
What is Aptevo Therapeutics EV/EBITDA?
The current EV/EBITDA of APVO is -0.12
What is the all time high EV/EBITDA for Aptevo Therapeutics?
Aptevo Therapeutics all-time high EV/EBITDA is 0.67
What is APVO EV/EBITDA year-to-date change?
Aptevo Therapeutics EV/EBITDA has changed by +0.01 (+7.69%) since the beginning of the year
What is Aptevo Therapeutics EV/EBITDA year-on-year change?
Over the past year, APVO EV/EBITDA has changed by -0.41 (-141.38%)